Tibsovo Interactions
There are 580 drugs known to interact with Tibsovo (ivosidenib), along with 2 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 248 are major, 314 are moderate, and 18 are minor.
- View all 580 medications that may interact with Tibsovo
- View Tibsovo alcohol/food interactions (2)
- View Tibsovo disease interactions (2)
Most frequently checked interactions
View interaction reports for Tibsovo (ivosidenib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Advate (antihemophilic factor)
- Alimta (pemetrexed)
- amitriptyline
- Aubagio (teriflunomide)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Braftovi (encorafenib)
- Brineura (cerliponase alfa)
- Caprelsa (vandetanib)
- clonazepam
- clonidine
- Cosentyx (secukinumab)
- Crestor (rosuvastatin)
- Crixivan (indinavir)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Humira (adalimumab)
- Kalydeco (ivacaftor)
- losartan
- Lyrica (pregabalin)
- magnesium oxide
- Ozempic (semaglutide)
- Retrovir (zidovudine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tegretol (carbamazepine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
Tibsovo alcohol/food interactions
There are 2 alcohol/food interactions with Tibsovo (ivosidenib).
Tibsovo disease interactions
There are 2 disease interactions with Tibsovo (ivosidenib) which include:
Report options
More about Tibsovo (ivosidenib)
- Tibsovo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Vincristine
Vincristine systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
